deltatrials
Terminated NA INTERVENTIONAL 2-arm NCT03584269

Innovation in NOn Invasive Ventilation in COPD Patients Treated by Long Term Oxygen Therapy (INOV-LTOT)

Non Invasive Ventilation and Nocturnal Alveolar Hypoventilation in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated by Long Term Oxygen Therapy at Home

Sponsor: AGIR à Dom

Updated 6 times since 2018 Last updated: Feb 9, 2021 Started: Jun 28, 2018 Primary completion: Jul 9, 2018 Completion: Sep 23, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Recruiting difficulties

A NA clinical study on Chronic Obstructive Pulmonary Disease, this trial is terminated or withdrawn. The trial is conducted by AGIR à Dom and has accumulated 6 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Aug 2018 – ~Feb 2020 · 18 months · monthly snapshotRecruiting~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshotTerminated~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshotTerminated~Mar 2021 – ~Jul 2024 · 40 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Mar 2021 — Jul 2024 [monthly]

    Terminated NA

  4. Jan 2021 — Mar 2021 [monthly]

    Terminated NA

  5. Feb 2020 — Jan 2021 [monthly]

    Terminated NA

    Status: RecruitingTerminated

Show 1 earlier version
  1. Aug 2018 — Feb 2020 [monthly]

    Recruiting NA

    First recorded

Jun 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AGIR à Dom
  • ResMed
  • University Hospital, Grenoble
Data source: University Hospital, Grenoble

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations